Hepatitis C Antibody Testing Service

This service was added to the  Community Pharmacy Contractual Framework (CPCF) in 2020, planned to commence 1st April 2020.The introduction was delayed by five months because of the COVID-19 pandemic and commenced 1st September 2020.

The service provides a point of care testing (POCT) for Hepatitis C  Virus (HCV) antibodies to people who inject drugs (PWIDs), using the InTec Rapid AntiHCV Test. 

What is the purpose of the HCV antibody testing service ?  

  • Increase levels of testing for HCV amongst PWIDS who are not engaged in community drug and alcohol treatment services to: 
  1. increase the number of diagnoses of HCV infection
  2. permit effective interventions to lessen the burden of illness to the individual
  3. decrease long-term costs of treatment; and d. decrease onward transmission of HCV.

Who is eligible for the HCV antibody  testing service?

  • Individuals who inject illicit drugs, e.g. steroids or heroin and
  • who haven’t yet moved to the point of accepting treatment for their substance use.

Where people test positive for Hep C antibodies, they will be referred for a confirmatory test and treatment, where appropriate.

Payment

  • £36 per POCT, plus the cost of the POCT (including VAT)
  • Claims to be made monthly, via the MYS portal.
  • Payments will be separately itemised on the FP34 Schedule of Payments. 

For more information refer to the 

Service Specification 

Hep C antibody testing SOP